Arkansas Legal Resource Navigator

42 U.S.C. § 285s — Purpose of Institute

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 285s — Purpose of Institute

**(a) General purpose** The general purpose of the National Human Genome Research Institute (in this subpart referred to as the “Institute”) is to characterize the structure and function of the human genome, including the mapping and sequencing of individual genes. Such purpose includes— (1) planning and coordinating the research goal of the genome project; (2) reviewing and funding research proposals; (3) developing training programs; (4) coordinating international genome research; (5) communicating advances in genome science to the public; and (6) reviewing and funding proposals to address the ethical and legal issues associated with the genome project (including legal issues regarding patents). **(b) Research training** The Director of the Institute may conduct and support research training— (1) for which fellowship support is not provided under [section 288 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section288&num=0&edition=prelim); and (2) that is not residency training of physicians or other health professionals. **(c) Amount available for ethical and legal issues** (1) Except as provided in paragraph (2), of the amounts appropriated to carry out subsection (a) for a fiscal year, the Director of the Institute shall make available not less than 5 percent for carrying out paragraph (6) of such subsection. (2) With respect to providing funds under subsection (a)(6) for proposals to address the ethical issues associated with the genome project, paragraph (1) shall not apply for a fiscal year if the Director of the Institute certifies to the Committee on Energy and Commerce of the House of Representatives, and to the Committee on Labor and Human Resources of the Senate, that the Director has determined that an insuff

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 285s

Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: f10d2857401bd333e9a9e76600f511c1181d6bce9b8c7fbfd1cd244c87822476. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:record_usc_654fac4aad49393a1745263b
Source file: Laws/federal/codes/united-states-code/title-42/section-285s-purpose-of-institute--e0f94c8698.md
Pages: Not recorded – Not recorded
Passage SHA-256: e53d587357a51dfff47bb42c652749d995362250819beda642e06ae8e98873b1

Source location: Title 42, Chapter 6A, § 285s; chapter-6a-public-health-service.md

Stored source content

**(a) General purpose** The general purpose of the National Human Genome Research Institute (in this subpart referred to as the “Institute”) is to characterize the structure and function of the human genome, including the mapping and sequencing of individual genes. Such purpose includes— (1) planning and coordinating the research goal of the genome project; (2) reviewing and funding research proposals; (3) developing training programs; (4) coordinating international genome research; (5) communicating advances in genome science to the public; and (6) reviewing and funding proposals to address the ethical and legal issues associated with the genome project (including legal issues regarding patents). **(b) Research training** The Director of the Institute may conduct and support research training— (1) for which fellowship support is not provided under [section 288 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section288&num=0&edition=prelim); and (2) that is not residency training of physicians or other health professionals. **(c) Amount available for ethical and legal issues** (1) Except as provided in paragraph (2), of the amounts appropriated to carry out subsection (a) for a fiscal year, the Director of the Institute shall make available not less than 5 percent for carrying out paragraph (6) of such subsection. (2) With respect to providing funds under subsection (a)(6) for proposals to address the ethical issues associated with the genome project, paragraph (1) shall not apply for a fiscal year if the Director of the Institute certifies to the Committee on Energy and Commerce of the House of Representatives, and to the Committee on Labor and Human Resources of the Senate, that the Director has determined that an insufficient number of such proposals meet the applicable requirements of sections 289 and 289a of this title.

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 287c — Transferred

### Statutory Notes #### Codification Section, act July 1, 1944, ch. 373, title IV, § 485B, as added Pub. L. 103–43, title XV, § 1521(2), June 10, 1993, 107 Stat. 180, which set out the purpose of the National Center for Human Genome Research, was renumbered section 464z–1 of act July 1, 1944, by Pub. L. 109–482, title I, § 101(c)(4)(A), Jan. 15, 2007, 120 Stat. 3681, and transferred to [section 285s of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section285s&num=0&edition=prelim). #### Prior Provisions Another prior section 287c, act July 1, 1944, ch. 373, title IV, § 483, as added Nov. 20, 1985, Pub. L. 99–158, § 2, 99 Stat. 867, and amended, which related to purpose of National Center for Nursing Research, was renumbered section 464V of act July 1, 1944, by Pub. L. 103–43, title XV, § 1511(b)(2), June 10, 1993, 107 Stat. 179, and transferred to [section 285q of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section285q&num=0&edition=prelim). A prior section 287c–1, act July 1, 1944, ch. 373, title IV, § 484, as added Nov. 20, 1985, Pub. L. 99–158, § 2, 99 Stat. 867, and amended, which related to specific authorities of the Director of the Center, was renumbered section 464W of act July 1, 1944, by Pub. L. 103–43, title XV, § 1511(b)(2), June 10, 1993, 107 Stat. 179, and transferred to [section 285q–1 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section285q-1&num=0&edition=prelim). A prior section 287c–2, act July 1, 1944, ch. 373, title IV, § 485, as added Nov. 20, 1985, Pub. L. 99–158, § 2, 99 Stat. 867, and amended, which related to the advisory council for the Center, was renumbered section 464X of act July 1, 1944, by Pub. L. 103–43, title XV, § 1511(b

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 287c

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

2 U.S.C. § 21 — Oath of Senators

The oath of office shall be administered by the President of the Senate to each Senator who shall be elected, previous to his taking his seat.

Source: Supplied U.S. Code snapshot — release unconfirmed · 2 U.S.C. § 21

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 288 — Ruth L. Kirschstein National Research Service Awards

**(a) Biomedical and behavioral research and research training; programs and institutions included; restriction; special consideration** (1) The Secretary shall— (A) provide Ruth L. Kirschstein National Research Service Awards for— (i) biomedical and behavioral research at the National Institutes of Health in matters relating to the cause, diagnosis, prevention, and treatment of the diseases or other health problems to which the activities of the National Institutes of Health and Administration 11 So in original. Reference to Administration probably should not appear. are directed; (ii) training at the National Institutes of Health and at the Administration 1 of individuals to undertake such research; (iii) biomedical and behavioral research and health services research (including research in primary medical care) at public and nonprofit private entities; and (iv) pre-doctoral and post-doctoral training at public and private institutions of individuals to undertake biomedical and behavioral research; (B) make grants to public and nonprofit private institutions to enable such institutions to make Ruth L. Kirschstein National Research Service Awards for research (and training to undertake biomedical and behavioral research) in the matters described in subparagraph (A)(i) to individuals selected by such institutions; and (C) provide contracts for scholarships and loan repayments in accordance with sections 288–4 and 288–5 22 See References in Text note below. of this title, subject to providing not more than an aggregate 50 such contracts during the fiscal years 1994 through 1996. A reference in this subsection to the National Institutes of Health shall be considered to include the institutes, agencies, divisions, and bureaus included in the

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 288

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 281 — Organization of National Institutes of Health

**(a) Relation to Public Health Service** The National Institutes of Health is an agency of the Service. **(b) National research institutes and national centers** The following agencies of the National Institutes of Health are national research institutes or national centers: (1) The National Cancer Institute. (2) The National Heart, Lung, and Blood Institute. (3) The National Institute of Diabetes and Digestive and Kidney Diseases. (4) The National Institute of Arthritis and Musculoskeletal and Skin Diseases. (5) The National Institute on Aging. (6) The National Institute of Allergy and Infectious Diseases. (7) The Eunice Kennedy Shriver National Institute of Child Health and Human Development. (8) The National Institute of Dental and Craniofacial Research. (9) The National Eye Institute. (10) The National Institute of Neurological Disorders and Stroke. (11) The National Institute on Deafness and Other Communication Disorders. (12) The National Institute on Alcohol Abuse and Alcoholism. (13) The National Institute on Drug Abuse. (14) The National Institute of Mental Health. (15) The National Institute of General Medical Sciences. (16) The National Institute of Environmental Health Sciences. (17) The National Institute of Nursing Research. (18) The National Institute of Biomedical Imaging and Bioengineering. (19) The National Human Genome Research Institute. (20) The National Library of Medicine. (21) The National Center for Advancing Translational Sciences. (22) The John E. Fogarty International Center for Advanced Study in the Health Sciences. (23) The National Center for Complementary and Integrative Health. (24) The National Institute on Minority Health and Health Disparities. (25) Any other national center that, as an agency separate from

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 281

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 285s — Purpose of Institute

Page 765 TITLE 42—THE PUBLIC HEALTH AND WELFARE § 285s ‘‘(3) The development of advanced genetic and mo- lecular imaging techniques is necessary to continue the current rapid pace of discovery in molecular biol- ogy. ‘‘(4) Advances in telemedicine, and teleradiology in particular, are increasingly important in the delivery of high quality, reliable medical care to rural citizens and other underserved populations. To fulfill the promise of telemedicine and related technologies fully, a structure is needed at the NIH to support basic research focused on the acquisition, trans- mission, processing, and optimal display of images. ‘‘(5) A number of Federal departments and agencies support imaging and engineering research with po- tential medical applications, but a central coordi- nating body, preferably housed at the NIH, is needed to coordinate these disparate efforts and facilitate the transfer of technologies with medical applica- tions. ‘‘(6) Several breakthrough imaging technologies, including magnetic resonance imaging (‘MRI’) and computed tomography (‘CT’), have been developed primarily abroad, in large part because of the absence of a home at the NIH for basic research in imaging and related fields. The establishment of a central focus for imaging and bioengineering research at the NIH would promote both scientific advance and United States economic development. ‘‘(7) At a time when a consensus exists to add sig- nificant resources to the NIH in coming years, it is appropriate to modernize the structure of the NIH to ensure that research dollars are expended more effec- tively and efficiently and that the fields of medical science that have contributed the most to the detec- tion, diagnosis, and treatment of disease in recent years receive

Source: Supplied 2024 U.S. Code historical extraction · 42 U.S.C. § 285s

Stored review status: historical_2024_not_currentness_verified. Same stored citation; legal effect and authority still require review.